English Overview
We are pleased to invite you to the webinar titled ‘JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations'. Where our speakers will be sharing their experience through clinical cases of RA and PsA. As well as, the latest long-term efficacy and safety related data.
This Activity for
- Resident / Fellow
- Physician
- Clinical Pharmacy
What I will learn?
- Providing the data of approved JAK inhibitors in the management of Rheumatoid Arthritis and IL 17 in the management of Psoriatic Arthritis.
- Sharing clinical cases of RA and PsA.
- Safety and efficacy profile of JAK Inhibitor & IL17.
- Sharing clinical cases of RA and PsA.
- Safety and efficacy profile of JAK Inhibitor & IL17.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations Certificate
Certificate |
Certificate | Free |
VAT 15% Included
